| Description |
Recombinant Human CSPG5 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Val31-Cys423. |
| Purity |
> 95% as determined by Tris-Bis PAGE;> 94% as determined by HPLC |
| Accession |
AAQ04774 |
| Target Symbol |
CSPG5 |
| Synonyms |
Chondroitin sulfate proteoglycan 5;Acidic leucine-rich EGF-like domain-containing brain protein;Neuroglycan C;CALEB;chondroitin sulfate proteoglycan 5 (neuroglycan C;MGC44034;Neuroglycan C;NGC;NGCAcidic leucine-rich EGF-like domain-containing brain protein |
| Species |
Human |
| Expression System |
HEK293 |
| Tag |
C-His |
| Expression Range |
Val31-Cys423 |
| Mol. Weight |
The protein has a predicted MW of 42.47 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Tris-Bis PAGE result. |
| Form |
Lyophilized |
| Formulation |
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Endotoxin |
Less than 1EU per ug by the LAL method. |
| Storage |
Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping |
Shipped at ambient temperature. |
| Gene Background |
Chondroitin sulfate proteoglycan 5 (CSPG-5), also known as neuroglycan C, has been previously associated to differentiation since it shapes neurite growth and synapse forming. CSPG-5 expression shifts in brain areas of the default mode network of suicide victims, which may reflect an impact in the pathogenesis of psychiatric diseases or support diagnostic power. |
